The Safe-N-Medtech initiative just kicked off last week in Bilbao, in a meeting hosted by Osteba, the HTA Unit of the Health Ministry of the Basque Country (Spain) in collaboration with BIOPRAXIS-BIOKERALTY. The project is coordinated by TECNAN...
Read more
After serving as editor-in-chief of Nanomedicine: Nanotechnology, Biology and Medicine for over seven years, Lajos Balogh knew that he had the skills and expertise needed to run an academic journal. An ardent open access (OA) advocate, Balogh...
Read more
On May 23, 2019, the Centre Tarraconense El Seminari will host the 11th Research Day organized by the Catalan Health Institute involving several researchers from the Vall d’Hebron Research Institute (VHIR). This year, is dedicated to...
Read more
The Vall d’Hebron Research Institute’s Oncology Department (VHIR) has organized the second mini-symposium ‘OMICs in Cancer Research’ in which speakers from different institutions and countries, reviewed the current state...
Read more
On the occasion of World Colorectal Cancer Day, this Sunday, March 31, CIBBIM-Nanomedicine. Biomedical Research in Digestive Tract Tumors of the Institut de Recerca Vall d’hebron (VHIR) wants to raise awareness among the population about...
Read moreDiana Rafael, Fernanda Andrade, Francesc Martinez-Trucharte, Jana Basas, Joaquín Seras-Franzoso , Marta Palau Xavier Gomis, Marc Pérez-Burgos , Alberto Blanco, Alba López-Fernández, Roberto Vélez, Ibane Abasolo, Màrius Aguirre, Joan Gavaldà, and...
Read more
Next Monday, November 19, Vall d’Hebron will hold a seminar focused on Lysosomal Rare Disorders: Focus on Fabry Disease. The seminar is part of the Rare Diseases Program at the Vall d’Hebron Campus, in collaboration with the European...
Read more
Dr. Joan Genescà, head of the Liver Diseases research group and Dr. María Martell, group researcher and head of the Advanced Liver Disease laboratory, from the Liver Diseases group at VHIR, have received funding for a European research project in...
Read more
The European Commission, upon proposal from the European Medicines Agency (EMA), has designated Gefitinib as an orphan drug for Fanconi anemia. This orally administered product is currently indicated for the treatment of lung cancer. The studies...
Read more
Pre-doctoral researcher Mónica Vall, from the research group in Renal Physiopathology – CIBBIM Nanomedicine led by Dr. Anna Meseguer, won the prize for the best poster – short communication from the XLIII National Congress of...
Read more
Recently, Dr. J Raúl Herance, co-head of the Molecular Medical Imaging group at the Vall d’Hebron Research Institute (VHIR) has been elected to the position of Co-chair of the Spanish Group of the European Molecular Imaging Society. It will...
Read moreMendez O, Peg V, Salvans C, Pujals M, Fernandez Y, Abasolo I, Perez J, Matres A, Valeri M, Gregori J, Villarreal L, Schwartz S, Ramon Y Cajal S, Tabernero J, Cortes J, Arribas J, Villanueva J Clin Cancer Res. 2018 Aug 22. pii...
Read more
